- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01635933
A Comparison of AIR OPTIX® COLORS Versus FRESHLOOK® COLORBLENDS
April 25, 2014 updated by: Alcon Research
A Comparison of a Colored Silicone Hydrogel Lens Versus a Colored HEMA Lens
The purpose of this study was to evaluate the overall comfort of AIR OPTIX® COLORS compared to FRESHLOOK® COLORBLENDS in habitual wearers of the FRESHLOOK® COLORBLENDS .
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
370
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Able and willing to sign the Informed Consent document. If under legal age of consent, legally authorized representative must sign also Informed Consent document.
- Able to achieve visual acuity of at least 20/30 (Snellen) in each eye at distance with contact lenses and best corrected visual acuity (BCVA) ≥ 20/25 in each eye.
- Manifest cylinder less than or equal to 0.75 diopters (within the previous year) in each eye.
- Successful wear of FRESHLOOK® COLORBLENDS spherical soft contact lenses in both eyes (in the protocol-specified colors) during the past three months for a minimum of 5 days per week and 8 hours per day.
- History of at least 5 days of successful use with both lenses (minimum of 8 hours/day) of one of the protocol-specified lens care solutions/multi-purpose solutions (MPS).
- Other protocol-specified inclusion criteria may apply.
Exclusion Criteria:
- Any ocular or systemic medical condition that may, in the opinion of the investigator, preclude safe administration of the test articles or affect the results of this study.
- Wears habitual lenses in an extended wear modality (sleeping in lenses overnight / not removing lenses on a daily basis).
- Monovision, monocular (only one eye with functional vision) or fit with only one lens.
- History of intolerance or hypersensitivity to any component of the test articles.
- Use of any over-the-counter or prescribed topical ocular medications within the previous 7 days (excluding rewetting drops).
- Moderate or severe corneal edema, corneal vascularization, corneal staining, injection, tarsal abnormalities, "other" complications; and any corneal infiltrates.
- Current or history of ocular infection, severe inflammation, or disease within previous 6 months.
- Any systemic disease (including allergies, respiratory infections or colds) that may affect the eye or be exacerbated by use of contact lenses or contact lens solutions.
- Participation in any investigational clinical study within previous 30 days.
- Other protocol-defined exclusion criteria may apply.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: AIR OPTIX® COLORS
Lotrafilcon B contact lens with color worn in daily wear modality for 4 weeks.
Lenses were worn bilaterally for a minimum of 5 days per week, 8 hours per day.
|
Silicone hydrogel contact lens with color.
Other Names:
|
|
Active Comparator: FRESHLOOK® COLORBLENDS
Phemfilcon A contact lens with color worn in daily wear modality for 4 weeks, with a replacement pair dispensed at 14 days.
Lenses were worn bilaterally for a minimum of 5 days per week, 8 hours per day.
|
Hydrogel contact lens with color.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Subjective Rating of Overall Comfort
Time Frame: Up to Day 28
|
Overall comfort, as rated by the participant on a 10-point scale, with 1 being poor and 10 being excellent.
The participant rated both eyes together by providing one single rating.
|
Up to Day 28
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Subjective Rating of Overall Vision
Time Frame: Up to Day 28
|
Overall vision, as rated by the participant on a 10-point scale, with 1 being poor and 10 being excellent.
The participant rated both eyes together by providing one single rating.
|
Up to Day 28
|
|
Proportion of Subjects Preferring Study Lens (Strongly or Somewhat)
Time Frame: Day 28
|
Participants were asked to compare the study lenses to their habitual lenses using a 5-point scale: strongly prefer study lenses, somewhat prefer study lenses, no preference, somewhat prefer habitual lenses, and strongly prefer habitual lenses, where 'study lenses' refer to either test or control depending on the treatment group.
Proportion of subjects preferring study lens is reported as the percentage of participants who strongly or somewhat preferred the study lens.
|
Day 28
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Sharon Holden Thomas, O.D., Alcon Research
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2012
Primary Completion (Actual)
September 1, 2012
Study Completion (Actual)
September 1, 2012
Study Registration Dates
First Submitted
July 5, 2012
First Submitted That Met QC Criteria
July 9, 2012
First Posted (Estimate)
July 10, 2012
Study Record Updates
Last Update Posted (Estimate)
May 9, 2014
Last Update Submitted That Met QC Criteria
April 25, 2014
Last Verified
April 1, 2014
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- C-12-005
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myopia
-
Tianjin Medical University Eye HospitalNot yet recruitingProgressive Myopia | Pediatric Myopia | Orthokeratology-related Myopia Progression
-
Shanghai General Hospital, Shanghai Jiao Tong University...Not yet recruitingMyopia | Myopia, ProgressiveChina
-
SightGlass Vision, Inc.Recruiting
-
University of FaisalabadCompletedRefractive Errors | Myopia | Progressive MyopiaPakistan
-
SightGlass Vision, Inc.RecruitingMyopia | Myopia Progression | Juvenile MyopiaUnited States
-
Shanghai Eye Disease Prevention and Treatment CenterEnrolling by invitationMyopia, Child Myopia ProgressionChina
-
He Eye HospitalNot yet recruiting
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityActive, not recruiting
-
University Eye Hospital, FreiburgActive, not recruiting
-
University of BradfordUniversity of Huddersfield; CooperVision International Limited (CVIL)Enrolling by invitationMyopia, ProgressiveUnited Kingdom
Clinical Trials on Lotrafilcon B contact lens with color
-
CIBA VISIONCompleted
-
CIBA VISIONUniversity of WaterlooCompleted
-
Alcon ResearchCompleted
-
Alcon ResearchCompletedRefractive Error | Myopia
-
CIBA VISIONCompletedCosmetic Appearance
-
Johnson & Johnson Vision Care, Inc.Visioncare Research Ltd.Completed
-
CIBA VISIONUniversity of WaterlooCompleted
-
CIBA VISIONCompleted